{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:42:00Z","timestamp":1790703720173,"version":"4.1.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NHC Key Laboratory of Drug Addiction Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, China","award":["2020DAMOP-008"],"award-info":[{"award-number":["2020DAMOP-008"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773925"],"award-info":[{"award-number":["81773925"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730096"],"award-info":[{"award-number":["81730096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Natural Science Foundation","award":["7212156"],"award-info":[{"award-number":["7212156"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-1-I2M-026"],"award-info":[{"award-number":["2021-1-I2M-026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11064-022-03586-0","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T06:14:26Z","timestamp":1648534466000},"page":"3627-3634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Distribution of \u03b1-Synuclein Aggregation in the Peripheral Tissues"],"prefix":"10.1007","volume":"47","author":[{"given":"Yan-yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-tian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6411-0474","authenticated-orcid":false,"given":"Yu-He","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"3586_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jns.2011.05.027","volume":"310","author":"E Tolosa","year":"2011","unstructured":"Tolosa E, Pont-Sunyer C (2011) Progress in defining the premotor phase of Parkinson\u2019s disease. J Neurol Sci 310:4\u20138","journal-title":"J Neurol Sci"},{"key":"3586_CR2","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00702-015-1405-5","volume":"122","author":"KA Jellinger","year":"2015","unstructured":"Jellinger KA (2015) Neuropathobiology of non-motor symptoms in Parkinson disease. J Neural Transm (Vienna) 122:1429\u20131440","journal-title":"J Neural Transm (Vienna)"},{"key":"3586_CR3","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.2147\/NDT.S219288","volume":"15","author":"AM Romosan","year":"2019","unstructured":"Romosan AM, Dehelean L, Romosan RS, Andor M, Bredicean AC, Simu MA (2019) Affective theory of mind in Parkinson\u2019s disease: the effect of cognitive performance. Neuropsychiatr Dis Treat 15:2521\u20132535","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3586_CR4","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1097\/MNM.0000000000001098","volume":"40","author":"H Kim","year":"2019","unstructured":"Kim H, Oh M, Oh JS, Moon H, Chung SJ, Lee CS, Kim JS (2019) Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson\u2019s disease with mild cognitive impairment. Nucl Med Commun 40:1216\u20131223","journal-title":"Nucl Med Commun"},{"key":"3586_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fnmol.2019.00218","volume":"12","author":"QQ Chen","year":"2019","unstructured":"Chen QQ, Haikal C, Li W, Li JY (2019) Gut inflammation in association with pathogenesis of parkinson\u2019s disease. Front Mol Neurosci 12:218","journal-title":"Front Mol Neurosci"},{"key":"3586_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00415-019-09551-2","volume":"267","author":"P Solla","year":"2019","unstructured":"Solla P, Masala C, Liscia A, Piras R, Ercoli T, Fadda L, Hummel T, Haenher A, Defazio G (2019) Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson\u2019s disease. J Neurol 267:57\u201363","journal-title":"J Neurol"},{"key":"3586_CR7","first-page":"185","volume":"46","author":"Y Hu","year":"2015","unstructured":"Hu Y, Zhang W (2015) Parkinson disease with rapid eye movement sleep behavior disorder. Sheng Li Ke Xue Jin Zhan 46:185\u2013190","journal-title":"Sheng Li Ke Xue Jin Zhan"},{"key":"3586_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1001\/jamaneurol.2015.2904","volume":"73","author":"J Liebenthal","year":"2016","unstructured":"Liebenthal J, Valerio J, Ruoff C, Mahowald M (2016) A case of rapid eye movement sleep behavior disorder in parkinson disease treated with sodium oxybate. JAMA Neurol 73:126\u2013127","journal-title":"JAMA Neurol"},{"key":"3586_CR9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A (2017) Epidemiology of parkinson\u2019s disease. J Neural Transm (Vienna) 124:901\u2013905","journal-title":"J Neural Transm (Vienna)"},{"key":"3586_CR10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/mds.27037","volume":"32","author":"TJ Collier","year":"2017","unstructured":"Collier TJ, Kanaan NM, Kordower JH (2017) Aging and parkinson\u2019s disease: different sides of the same coin? Mov Disord 32:983\u2013990","journal-title":"Mov Disord"},{"key":"3586_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.envint.2016.08.017","volume":"96","author":"PC Lee","year":"2016","unstructured":"Lee PC, Liu LL, Sun Y, Chen YA, Liu CC, Li CY, Yu HL, Ritz B (2016) Traffic-related air pollution increased the risk of parkinson\u2019s disease in Taiwan: a nationwide study. Environ Int 96:75\u201381","journal-title":"Environ Int"},{"key":"3586_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"3586_CR13","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","volume":"8","author":"L Maroteaux","year":"1988","unstructured":"Maroteaux L, Campanelli JT, Scheller RH (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. The J Neurosci\u202f: Off J Soc Neurosci 8:2804\u20132815","journal-title":"The J Neurosci : Off J Soc Neurosci"},{"key":"3586_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E (2013) The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci 14:38\u201348","journal-title":"Nat Rev Neurosci"},{"key":"3586_CR15","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","volume":"273","author":"WS Davidson","year":"1998","unstructured":"Davidson WS, Jonas A, Clayton DF, George JM (1998) Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273:9443\u20139449","journal-title":"J Biol Chem"},{"key":"3586_CR16","doi-asserted-by":"publisher","first-page":"19666","DOI":"10.1073\/pnas.0807826105","volume":"105","author":"CC Jao","year":"2008","unstructured":"Jao CC, Hegde BG, Chen J, Haworth IS, Langen R (2008) Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement. Proc Natl Acad Sci U S A 105:19666\u201319671","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3586_CR17","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","volume":"307","author":"D Eliezer","year":"2001","unstructured":"Eliezer D, Kutluay E, Bussell R Jr, Browne G (2001) Conformational properties of alpha-synuclein in its free and lipid-associated states. J Mol Biol 307:1061\u20131073","journal-title":"J Mol Biol"},{"key":"3586_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s12035-012-8325-2","volume":"47","author":"SN Witt","year":"2013","unstructured":"Witt SN (2013) Molecular chaperones, alpha-synuclein, and neurodegeneration. Mol Neurobiol 47:552\u2013560","journal-title":"Mol Neurobiol"},{"key":"3586_CR19","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1007\/s12035-016-0114-x","volume":"54","author":"V Coppola-Segovia","year":"2017","unstructured":"Coppola-Segovia V, Cavarsan C, Maia FG, Ferraz AC, Nakao LS, Lima MM, Zanata SM (2017) ER stress induced by tunicamycin triggers alpha-synuclein oligomerization, dopaminergic neurons death and locomotor impairment: a new model of parkinson\u2019s disease. Mol Neurobiol 54:5798\u20135806","journal-title":"Mol Neurobiol"},{"key":"3586_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha EM, De Miranda B, Sanders LH (2018) Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in parkinson\u2019s disease. Neurobiol Dis 109:249\u2013257","journal-title":"Neurobiol Dis"},{"key":"3586_CR21","doi-asserted-by":"publisher","first-page":"7619","DOI":"10.1074\/jbc.274.12.7619","volume":"274","author":"BI Giasson","year":"1999","unstructured":"Giasson BI, Uryu K, Trojanowski JQ, Lee VM (1999) Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem 274:7619\u20137622","journal-title":"J Biol Chem"},{"key":"3586_CR22","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1021\/bi027166s","volume":"42","author":"LA Munishkina","year":"2003","unstructured":"Munishkina LA, Phelan C, Uversky VN, Fink AL (2003) Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes. Biochemistry 42:2720\u20132730","journal-title":"Biochemistry"},{"key":"3586_CR23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-4159.2007.04764.x","volume":"103","author":"VN Uversky","year":"2007","unstructured":"Uversky VN (2007) Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. J Neurochem 103:17\u201337","journal-title":"J Neurochem"},{"key":"3586_CR24","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1111\/febs.12824","volume":"281","author":"AN Stefanovic","year":"2014","unstructured":"Stefanovic AN, Stockl MT, Claessens MM, Subramaniam V (2014) alpha-synuclein oligomers distinctively permeabilize complex model membranes. FEBS J 281:2838\u20132850","journal-title":"FEBS J"},{"key":"3586_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels T, Choi JG, Selkoe DJ (2011) alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477:107\u2013110","journal-title":"Nature"},{"key":"3586_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1750-1326-4-9","volume":"4","author":"MR Cookson","year":"2009","unstructured":"Cookson MR (2009) alpha-synuclein and neuronal cell death. Mol Neurodegener 4:9","journal-title":"Mol Neurodegener"},{"key":"3586_CR27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nature14526","volume":"522","author":"SJ Lee","year":"2015","unstructured":"Lee SJ, Masliah E (2015) Neurodegeneration: aggregates feel the strain. Nature 522:296\u2013297","journal-title":"Nature"},{"key":"3586_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134","journal-title":"Cell Tissue Res"},{"issue":"Suppl 1","key":"3586_CR29","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1002\/mds.22637","volume":"25","author":"DW Dickson","year":"2010","unstructured":"Dickson DW, Uchikado H, Fujishiro H, Tsuboi Y (2010) Evidence in favor of braak staging of parkinson\u2019s disease. Mov Disord 25(Suppl 1):S78-82","journal-title":"Mov Disord"},{"key":"3586_CR30","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S1474-4422(21)00219-2","volume":"20","author":"Y Sharabi","year":"2021","unstructured":"Sharabi Y, Vatine GD, Ashkenazi A (2021) Parkinson\u2019s disease outside the brain: targeting the autonomic nervous system. Lancet Neurol 20:868\u2013876","journal-title":"Lancet Neurol"},{"key":"3586_CR31","doi-asserted-by":"publisher","first-page":"a024091","DOI":"10.1101\/cshperspect.a024091","volume":"8","author":"J Burre","year":"2018","unstructured":"Burre J, Sharma M, Sudhof TC (2018) Cell Biology and Pathophysiology of alpha-Synuclein. Cold Spring Harb Perspect Med 8:a024091","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3586_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong YC, Krainc D (2017) alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med 23:1\u201313","journal-title":"Nat Med"},{"key":"3586_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5599\/admet.3.1.159","volume":"3","author":"CA Bates","year":"2015","unstructured":"Bates CA, Fu S, Ysselstein D, Rochet JC, Zheng W (2015) Expression and transport of alpha-synuclein at the blood-cerebrospinal fluid barrier and effects of manganese exposure. ADMET DMPK 3:15\u201333","journal-title":"ADMET DMPK"},{"key":"3586_CR34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","volume":"128","author":"M Shi","year":"2014","unstructured":"Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, Li Y, Aro P, Dator R, He C, Hipp MJ, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Banks WA, Zhang J (2014) Plasma exosomal alpha-synuclein is likely CNS-derived and increased in parkinson\u2019s disease. Acta Neuropathol 128:639\u2013650","journal-title":"Acta Neuropathol"},{"key":"3586_CR35","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/brain\/awq008","volume":"133","author":"Z Hong","year":"2010","unstructured":"Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J (2010) DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of parkinson\u2019s disease. Brain 133:713\u2013726","journal-title":"Brain"},{"key":"3586_CR36","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.1038\/s41598-019-42399-0","volume":"9","author":"K Kakuda","year":"2019","unstructured":"Kakuda K, Ikenaka K, Araki K, So M, Aguirre C, Kajiyama Y, Konaka K, Noi K, Baba K, Tsuda H, Nagano S, Ohmichi T, Nagai Y, Tokuda T, El-Agnaf OMA, Ogi H, Goto Y, Mochizuki H (2019) Ultrasonication-based rapid amplification of alpha-synuclein aggregates in cerebrospinal fluid. Sci Rep 9:6001","journal-title":"Sci Rep"},{"key":"3586_CR37","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/nan.12524","volume":"45","author":"H Ning","year":"2019","unstructured":"Ning H, Wu Q, Han D, Yao T, Wang J, Lu W, Lv S, Jia Q, Li X (2019) Baseline concentration of misfolded alpha-synuclein aggregates in cerebrospinal fluid predicts risk of cognitive decline in parkinson\u2019s disease. Neuropathol Appl Neurobiol 45:398\u2013409","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3586_CR38","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","volume":"69","author":"S Hall","year":"2012","unstructured":"Hall S, Ohrfelt A, Constantinescu R, Andreasson U, Surova Y, Bostrom F, Nilsson C, Hakan W, Decraemer H, Nagga K, Minthon L, Londos E, Vanmechelen E, Holmberg B, Zetterberg H, Blennow K, Hansson O (2012) Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders. Arch Neurol 69:1445\u20131452","journal-title":"Arch Neurol"},{"key":"3586_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000112832","volume":"5","author":"R Barbour","year":"2008","unstructured":"Barbour R, Kling K, Anderson JP, Banducci K, Cole T, Diep L, Fox M, Goldstein JM, Soriano F, Seubert P, Chilcote TJ (2008) Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis 5:55\u201359","journal-title":"Neurodegener Dis"},{"key":"3586_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neulet.2010.06.009","volume":"480","author":"M Shi","year":"2010","unstructured":"Shi M, Zabetian CP, Hancock AM, Ginghina C, Hong Z, Yearout D, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Leverenz JB, Zhang J (2010) Significance and confounders of peripheral DJ-1 and alpha-synuclein in parkinson\u2019s disease. Neurosci Lett 480:78\u201382","journal-title":"Neurosci Lett"},{"key":"3586_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40035-019-0155-y","volume":"8","author":"C Tian","year":"2019","unstructured":"Tian C, Liu G, Gao L, Soltys D, Pan C, Stewart T, Shi M, Xie Z, Liu N, Feng T, Zhang J (2019) Erythrocytic alpha-synuclein as a potential biomarker for parkinson\u2019s disease. Transl Neurodegener 8:15","journal-title":"Transl Neurodegener"},{"key":"3586_CR42","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","volume":"17","author":"N Fabelo","year":"2011","unstructured":"Fabelo N, Martin V, Santpere G, Marin R, Torrent L, Ferrer I, Diaz M (2011) Severe alterations in lipid composition of frontal cortex lipid rafts from parkinson\u2019s disease and incidental parkinson\u2019s disease. Mol Med 17:1107\u20131118","journal-title":"Mol Med"},{"key":"3586_CR43","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bpa.12370","volume":"26","author":"A Atik","year":"2016","unstructured":"Atik A, Stewart T, Zhang J (2016) Alpha-synuclein as a biomarker for parkinson\u2019s disease. Brain Pathol 26:410\u2013418","journal-title":"Brain Pathol"},{"key":"3586_CR44","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaneurol.2018.1487","volume":"75","author":"J Jankovic","year":"2018","unstructured":"Jankovic J, Goodman I, Safirstein B, Marmon TK, Schenk DB, Koller M, Zago W, Ness DK, Griffith SG, Grundman M, Soto J, Ostrowitzki S, Boess FG, Martin-Facklam M, Quinn JF, Isaacson SH, Omidvar O, Ellenbogen A, Kinney GG (2018) Safety and tolerability of multiple ascending doses of PRX002\/RG7935, an anti-alpha-synuclein monoclonal antibody patients With parkinson disease: a randomized clinical trial. JAMA Neurol 75:1206\u20131214","journal-title":"JAMA Neurol"},{"key":"3586_CR45","doi-asserted-by":"publisher","first-page":"e1267","DOI":"10.1212\/WNL.0000000000010404","volume":"95","author":"LM Chahine","year":"2020","unstructured":"Chahine LM, Beach TG, Brumm MC, Adler CH, Coffey CS, Mosovsky S, Caspell-Garcia C, Serrano GE, Munoz DG, White CL 3rd, Crary JF, Jennings D, Taylor P, Foroud T, Arnedo V, Kopil CM, Riley L, Dave KD, Mollenhauer B (2020) Systemic synuclein sampling, In vivo distribution of alpha-synuclein in multiple tissues and biofluids in parkinson disease. Neurology 95:e1267\u2013e1284","journal-title":"Neurology"},{"key":"3586_CR46","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1093\/brain\/awr015","volume":"134","author":"I Devic","year":"2011","unstructured":"Devic I, Hwang H, Edgar JS, Izutsu K, Presland R, Pan C, Goodlett DR, Wang Y, Armaly J, Tumas V, Zabetian CP, Leverenz JB, Shi M, Zhang J (2011) Salivary alpha-synuclein and DJ-1: potential biomarkers for Parkinson\u2019s disease. Brain 134:e178","journal-title":"Brain"},{"key":"3586_CR47","doi-asserted-by":"publisher","first-page":"e0151156","DOI":"10.1371\/journal.pone.0151156","volume":"11","author":"G Vivacqua","year":"2016","unstructured":"Vivacqua G, Latorre A, Suppa A, Nardi M, Pietracupa S, Mancinelli R, Fabbrini G, Colosimo C, Gaudio E, Berardelli A (2016) Abnormal salivary total and oligomeric alpha-synuclein in parkinson\u2019s disease. PLoS One 11:e0151156","journal-title":"PLoS One"},{"key":"3586_CR48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.parkreldis.2018.04.019","volume":"58","author":"J Shin","year":"2019","unstructured":"Shin J, Park SH, Shin C, Kim JH, Yun TJ, Kim HJ, Jeon B (2019) Submandibular gland is a suitable site for alpha synuclein pathology in Parkinson disease. Parkinsonism Relat Disord 58:35\u201339","journal-title":"Parkinsonism Relat Disord"},{"key":"3586_CR49","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S1474-4422(16)00080-6","volume":"15","author":"D Vilas","year":"2016","unstructured":"Vilas D, Iranzo A, Tolosa E, Aldecoa I, Berenguer J, Vilaseca I, Marti C, Serradell M, Lomena F, Alos L, Gaig C, Santamaria J, Gelpi E (2016) Assessment of alpha-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study. Lancet Neurol 15:708\u2013718","journal-title":"Lancet Neurol"},{"key":"3586_CR50","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/mds.25825","volume":"29","author":"A Iranzo","year":"2014","unstructured":"Iranzo A, Gelpi E, Tolosa E, Molinuevo JL, Serradell M, Gaig C, Santamaria J (2014) Neuropathology of prodromal Lewy body disease. Mov Disord 29:410\u2013415","journal-title":"Mov Disord"},{"key":"3586_CR51","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/mds.23344","volume":"26","author":"MG Cersosimo","year":"2011","unstructured":"Cersosimo MG, Perandones C, Micheli FE, Raina GB, Beron AM, Nasswetter G, Radrizzani M, Benarroch EE (2011) Alpha-synuclein immunoreactivity in minor salivary gland biopsies of Parkinson\u2019s disease patients. Mov Disord 26:188\u2013190","journal-title":"Mov Disord"},{"key":"3586_CR52","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","volume":"25","author":"HJ Lee","year":"2005","unstructured":"Lee HJ, Patel S, Lee SJ (2005) Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 25:6016\u20136024","journal-title":"J Neurosci"},{"key":"3586_CR53","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41598-017-16790-8","volume":"8","author":"QJ Yu","year":"2018","unstructured":"Yu QJ, Yu SY, Zuo LJ, Lian TH, Hu Y, Wang RD, Piao YS, Guo P, Liu L, Jin Z, Li LX, Chan P, Chen SD, Wang XM, Zhang W (2018) Parkinson disease with constipation: clinical features and relevant factors. Sci Rep 8:567","journal-title":"Sci Rep"},{"key":"3586_CR54","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/0016-5085(84)90079-9","volume":"87","author":"SJ Qualman","year":"1984","unstructured":"Qualman SJ, Haupt HM, Yang P, Hamilton SR (1984) Esophageal Lewy bodies associated with ganglion cell loss in achalasia Similarity to Parkinson\u2019s disease. Gastroenterology 87:848\u2013856","journal-title":"Gastroenterology"},{"key":"3586_CR55","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/BF00294234","volume":"79","author":"K Wakabayashi","year":"1990","unstructured":"Wakabayashi K, Takahashi H, Ohama E, Ikuta F (1990) Parkinson\u2019s disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol 79:581\u2013583","journal-title":"Acta Neuropathol"},{"issue":"Suppl","key":"3586_CR56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1679\/aohc.52.Suppl_191","volume":"52","author":"K Wakabayashi","year":"1989","unstructured":"Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F (1989) Lewy bodies in the enteric nervous system in Parkinson\u2019s disease. Arch Histol Cytol 52(Suppl):191\u2013194","journal-title":"Arch Histol Cytol"},{"key":"3586_CR57","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG, Arizona C (2010) Parkinson\u2019s disease, multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta neuropathologica 119:689\u2013702","journal-title":"Acta neuropathologica"},{"key":"3586_CR58","first-page":"7935820","volume":"2019","author":"B Ohlsson","year":"2019","unstructured":"Ohlsson B, Englund E (2019) Atrophic myenteric and submucosal neurons are observed in parkinson\u2019s disease. Parkinsons Dis 2019:7935820","journal-title":"Parkinsons Dis"},{"key":"3586_CR59","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/mds.23838","volume":"27","author":"KM Shannon","year":"2012","unstructured":"Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, Jaglin JA, Kordower JH (2012) Alpha-synuclein in colonic submucosa in early untreated parkinson\u2019s disease. Mov Disord 27:709\u2013715","journal-title":"Mov Disord"},{"key":"3586_CR60","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","volume":"138","author":"N Van Den Berge","year":"2019","unstructured":"Van Den Berge N, Ferreira N, Gram H, Mikkelsen TW, Alstrup AKO, Casadei N, Tsung-Pin P, Riess O, Nyengaard JR, Tamguney G, Jensen PH, Borghammer P (2019) Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta Neuropathol 138:535\u2013550","journal-title":"Acta Neuropathol"},{"issue":"627\u2013641","key":"3586_CR61","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, Shen C, Lee H, Kulkarni S, Pasricha PJ, Lee G, Pomper MG, Dawson VL, Dawson TM, Ko HS (2019) Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models parkinson\u2019s disease. Neuron 103(627\u2013641):e627","journal-title":"Neuron"},{"key":"3586_CR62","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","volume":"23","author":"C Challis","year":"2020","unstructured":"Challis C, Hori A, Sampson TR, Yoo BB, Challis RC, Hamilton AM, Mazmanian SK, Volpicelli-Daley LA, Gradinaru V (2020) Gut-seeded alpha-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci 23:327\u2013336","journal-title":"Nat Neurosci"},{"key":"3586_CR63","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202012095","author":"N Panicker","year":"2021","unstructured":"Panicker N, Ge P, Dawson VL, Dawson TM (2021) The cell biology of Parkinson\u2019s disease. J Cell Biol. https:\/\/doi.org\/10.1083\/jcb.202012095","journal-title":"J Cell Biol"},{"key":"3586_CR64","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s00415-019-09320-1","volume":"267","author":"M Lubomski","year":"2019","unstructured":"Lubomski M, Tan AH, Lim SY, Holmes AJ, Davis RL, Sue CM (2019) Parkinson\u2019s disease and the gastrointestinal microbiome. J Neurol 267:2507\u20132523","journal-title":"J Neurol"},{"key":"3586_CR65","doi-asserted-by":"publisher","first-page":"67","DOI":"10.14802\/jmd.18067","volume":"12","author":"HL Chiang","year":"2019","unstructured":"Chiang HL, Lin CH (2019) Altered gut microbiome and intestinal pathology in parkinson\u2019s disease. J Mov Disord 12:67\u201383","journal-title":"J Mov Disord"},{"key":"3586_CR66","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3389\/fneur.2019.00574","volume":"10","author":"SF Santos","year":"2019","unstructured":"Santos SF, de Oliveira HL, Yamada ES, Neves BC, Pereira A Jr (2019) The gut and parkinson\u2019s disease-a bidirectional pathway. Front Neurol 10:574","journal-title":"Front Neurol"},{"issue":"1469\u20131480","key":"3586_CR67","first-page":"e1412","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet MF, Keshavarzian A, Shannon KM, Krajmalnik-Brown R, Wittung-Stafshede P, Knight R, Mazmanian SK (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of parkinson\u2019s disease. Cell 167(1469\u20131480):e1412","journal-title":"Cell"},{"key":"3586_CR68","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","volume":"138","author":"N Van Den Berge","year":"2019","unstructured":"Van Den Berge N, Ferreira N, Gram H, Mikkelsen TW, Alstrup AKO, Casadei N, Tsung-Pin P, Riess O, Nyengaard JR, Tamguney G, Jensen PH, Borghammer P (2019) Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta neuropathological 138:535\u2013550","journal-title":"Acta neuropathological"},{"key":"3586_CR69","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1007\/s12035-018-1151-4","volume":"56","author":"TT Htike","year":"2019","unstructured":"Htike TT, Mishra S, Kumar S, Padmanabhan P, Gulyas B (2019) Peripheral biomarkers for early detection of alzheimer\u2019s and parkinson\u2019s diseases. Mol Neurobiol 56:2256\u20132277","journal-title":"Mol Neurobiol"},{"key":"3586_CR70","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1080\/14786419.2019.1591396","volume":"35","author":"R Spinelli","year":"2021","unstructured":"Spinelli R, Aimaretti FM, Lopez JA, Siano AS (2021) Amphibian skin extracts as source of bioactive multi-target agents against different pathways of alzheimer\u2019s disease. Nat Prod Res 35:686\u2013689","journal-title":"Nat Prod Res"},{"key":"3586_CR71","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.parkreldis.2020.11.017","volume":"82","author":"N Niemann","year":"2021","unstructured":"Niemann N, Billnitzer A, Jankovic J (2021) Parkinson\u2019s disease and skin. Parkinsonism Relat Disord 82:61\u201376","journal-title":"Parkinsonism Relat Disord"},{"key":"3586_CR72","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-017-1684-z","volume":"133","author":"K Doppler","year":"2017","unstructured":"Doppler K, Jentschke HM, Schulmeyer L, Vadasz D, Janzen A, Luster M, Hoffken H, Mayer G, Brumberg J, Booij J, Musacchio T, Klebe S, Sittig-Wiegand E, Volkmann J, Sommer C, Oertel WH (2017) Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson\u2019s disease. Acta Neuropathol 133:535\u2013545","journal-title":"Acta Neuropathol"},{"key":"3586_CR73","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/acn3.669","volume":"5","author":"G Melli","year":"2018","unstructured":"Melli G, Vacchi E, Biemmi V, Galati S, Staedler C, Ambrosini R, Kaelin-Lang A (2018) Cervical skin denervation associates with alpha-synuclein aggregates in Parkinson disease. Ann Clin Transl Neurol 5:1394\u20131407","journal-title":"Ann Clin Transl Neurol"},{"key":"3586_CR74","doi-asserted-by":"publisher","DOI":"10.3791\/59558","author":"E Vacchi","year":"2019","unstructured":"Vacchi E, Pinton S, Kaelin-Lang A, Melli G (2019) Targeting alpha synuclein aggregates in cutaneous peripheral nerve fibers by free-floating immunofluorescence assay. J Vis Exp. https:\/\/doi.org\/10.3791\/59558","journal-title":"J Vis Exp"},{"key":"3586_CR75","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/mds.27794","volume":"34","author":"K Tsukita","year":"2019","unstructured":"Tsukita K, Sakamaki-Tsukita H, Tanaka K, Suenaga T, Takahashi R (2019) Value of in vivo alpha-synuclein deposits in parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 34:1452\u20131463","journal-title":"Mov Disord"},{"key":"3586_CR76","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/978-3-030-78787-5_45","volume":"1339","author":"CC Zouboulis","year":"2021","unstructured":"Zouboulis CC, Makrantonaki E, Hossini AM (2021) Skin mirrors brain: a chance for alzheimer\u2019s disease research. Adv Exp Med Biol 1339:371\u2013380","journal-title":"Adv Exp Med Biol"},{"key":"3586_CR77","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/alzrt274","volume":"6","author":"PC Donaghy","year":"2014","unstructured":"Donaghy PC, McKeith IG (2014) The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimers Res Ther 6:46","journal-title":"Alzheimers Res Ther"},{"key":"3586_CR78","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.24567","volume":"79","author":"V Donadio","year":"2016","unstructured":"Donadio V, Incensi A, Piccinini C, Cortelli P, Giannoccaro MP, Baruzzi A, Liguori R (2016) Skin nerve misfolded alpha-synuclein in pure autonomic failure and parkinson disease. Ann Neurol 79:306\u2013316","journal-title":"Ann Neurol"},{"key":"3586_CR79","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/jnen\/nlx021","volume":"76","author":"V Donadio","year":"2017","unstructured":"Donadio V, Incensi A, Rizzo G, Scaglione C, Capellari S, Fileccia E, Avoni P, Liguori R (2017) Spine topographical distribution of skin alpha-synuclein deposits in idiopathic parkinson disease. J Neuropathol Exp Neurol 76:384\u2013389","journal-title":"J Neuropathol Exp Neurol"},{"key":"3586_CR80","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/ana.24182","volume":"75","author":"I Bodis-Wollner","year":"2014","unstructured":"Bodis-Wollner I, Kozlowski PB, Glazman S, Miri S (2014) Alpha-synuclein in the inner retina in parkinson disease. Ann Neurol 75:964\u2013966","journal-title":"Ann Neurol"},{"issue":"Suppl 2","key":"3586_CR81","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000113469","volume":"38","author":"K Wakabayashi","year":"1997","unstructured":"Wakabayashi K, Takahashi H (1997) Neuropathology of autonomic nervous system in parkinson\u2019s disease. Eur Neurol 38(Suppl 2):2\u20137","journal-title":"Eur Neurol"},{"key":"3586_CR82","doi-asserted-by":"publisher","first-page":"831","DOI":"10.5692\/clinicalneurol.48.831","volume":"48","author":"S Orimo","year":"2008","unstructured":"Orimo S (2008) Clinical and pathological study on early diagnosis of Parkinson\u2019s disease and dementia with Lewy bodies. Rinsho Shinkeigaku 48:831\u2013834","journal-title":"Rinsho Shinkeigaku"},{"key":"3586_CR83","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jamaneurol.2016.6155","volume":"74","author":"A Garrido","year":"2017","unstructured":"Garrido A, Aldecoa I, Gelpi E, Tolosa E (2017) Aggregation of alpha-synuclein in the gonadal tissue of 2 patients with parkinson disease. JAMA Neurol 74:606\u2013607","journal-title":"JAMA Neurol"},{"key":"3586_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1100\/2012\/489830","volume":"2012","author":"F Coppede","year":"2012","unstructured":"Coppede F (2012) Genetics and epigenetics of Parkinson\u2019s disease. Sci World J 2012:1\u201312","journal-title":"Sci World J"},{"key":"3586_CR85","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) Alpha-synuclein locus triplication causes parkinson\u2019s disease. Science 302:841","journal-title":"Science"},{"key":"3586_CR86","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, Destee A (2004) Alpha-synuclein locus duplication as a cause of familial parkinson\u2019s disease. Lancet 364:1167\u20131169","journal-title":"Lancet"},{"key":"3586_CR87","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/nm0602-600","volume":"8","author":"J Xu","year":"2002","unstructured":"Xu J, Kao SY, Lee FJ, Song W, Jin LW, Yankner BA (2002) Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in parkinson disease. Nat Med 8:600\u2013606","journal-title":"Nat Med"},{"key":"3586_CR88","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1021\/acs.biochem.8b00343","volume":"57","author":"MK Jain","year":"2018","unstructured":"Jain MK, Singh P, Roy S, Bhat R (2018) Comparative Analysis of the Conformation, Aggregation, Interaction, and Fibril Morphologies of Human alpha-, beta-, and gamma-Synuclein Proteins. Biochemistry 57:3830\u20133848","journal-title":"Biochemistry"},{"key":"3586_CR89","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.neuro.2019.07.007","volume":"74","author":"L Mezzaroba","year":"2019","unstructured":"Mezzaroba L, Alfieri DF, Colado Simao AN, Vissoci Reiche EM (2019) The role of zinc, copper, manganese and iron in neurodegenerative diseases. Neurotoxicology 74:230\u2013241","journal-title":"Neurotoxicology"},{"key":"3586_CR90","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1038\/ncomms3575","volume":"4","author":"L Bousset","year":"2013","unstructured":"Bousset L, Pieri L, Ruiz-Arlandis G, Gath J, Jensen PH, Habenstein B, Madiona K, Olieric V, Bockmann A, Meier BH, Melki R (2013) Structural and functional characterization of two alpha-synuclein strains. Nat Commun 4:2575","journal-title":"Nat Commun"},{"key":"3586_CR91","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M, Van den Haute C, Melki R, Baekelandt V (2015) alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522:340\u2013344","journal-title":"Nature"},{"key":"3586_CR92","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.neurobiolaging.2011.06.022","volume":"33","author":"AL Mougenot","year":"2012","unstructured":"Mougenot AL, Nicot S, Bencsik A, Morignat E, Verchere J, Lakhdar L, Legastelois S, Baron T (2012) Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol Aging 33:2225\u20132228","journal-title":"Neurobiol Aging"},{"key":"3586_CR93","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T, Wang ZY, Roybon L, Melki R, Li JY (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 128:805\u2013820","journal-title":"Acta Neuropathol"},{"key":"3586_CR94","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/emmm.201302475","volume":"5","author":"A Ulusoy","year":"2013","unstructured":"Ulusoy A, Rusconi R, Perez-Revuelta BI, Musgrove RE, Helwig M, Winzen-Reichert B, Di Monte DA (2013) Caudo-rostral brain spreading of alpha-synuclein through vagal connections. EMBO Mol Med 5:1119\u20131127","journal-title":"EMBO Mol Med"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03586-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-022-03586-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03586-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T10:29:34Z","timestamp":1700389774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-022-03586-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":94,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3586"],"URL":"https:\/\/doi.org\/10.1007\/s11064-022-03586-0","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"27 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare concerning this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}